Company Twist Bioscience Corporation

Equities

TWST

US90184D1000

Pharmaceuticals

Market Closed - Nasdaq 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
31.54 USD +1.48% Intraday chart for Twist Bioscience Corporation +12.84% -14.43%

Business Summary

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. It has miniaturized traditional chemical DNA synthesis reactions to write over one million short pieces of DNA on each silicon chip. It offers two product lines: synthetic biology tools and NGS tools, that address different needs of its customers across a variety of applications. It offers ribonucleic acid and protein products. Its synthetic biology products include synthetic genes and gene fragments, and oligonucleotide or oligo pools.

Number of employees: 919

Sales per Business

USD in Million2022Weight2023Weight Delta
Next Generation Sequencing Tools
50.5 %
99 48.8 % 124 50.5 % +24.56%
Synthetic Genes
30.0 %
62 30.2 % 74 30.0 % +19.56%
Antibody Discovery
9.5 %
24 11.9 % 23 9.5 % -4.13%
Oligo Pools
5.9 %
12 6.1 % 14 5.9 % +16.62%
DNA Libraries
4.2 %
6 3.0 % 10 4.2 % +65.90%

Sales per region

USD in Million2022Weight2023Weight Delta
Americas
61.7 %
122 60.2 % 151 61.7 % +23.51%
EMEA
29.1 %
62 30.5 % 71 29.1 % +15.00%
APAC
9.2 %
19 9.3 % 22 9.2 % +18.11%

Managers

Managers TitleAgeSince
Founder 69 04/13/04
Chief Executive Officer 50 01/13/01
Director of Finance/CFO 47 05/01
President 53 03/15/03
Chief Tech/Sci/R&D Officer - 20/23/20
Chief Tech/Sci/R&D Officer - 01/14/01
Chief Tech/Sci/R&D Officer - 01/20/01
Chief Tech/Sci/R&D Officer - -
Compliance Officer 53 27/21/27
Investor Relations Contact - 01/20/01

Members of the board

Members of the board TitleAgeSince
Director/Board Member 64 01/16/01
Director/Board Member 67 01/18/01
Director/Board Member 63 01/13/01
Director/Board Member 66 01/14/01
Director/Board Member 62 01/19/01
Founder 69 04/13/04
Director/Board Member 58 06/21/06
Chief Executive Officer 50 01/13/01
Director/Board Member 36 01/18/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 57,818,022 56,788,488 ( 98.22 %) 0 98.22 %

Shareholders

NameEquities%Valuation
ARK Investment Management LLC
12.01 %
6,943,975 12.01 % 238 M $
BlackRock Advisors LLC
9.537 %
5,513,977 9.537 % 189 M $
Vanguard Fiduciary Trust Co.
9.470 %
5,475,322 9.470 % 188 M $
JPMorgan Investment Management, Inc.
7.984 %
4,616,073 7.984 % 158 M $
Artisan Partners Holdings LP
6.440 %
3,723,305 6.440 % 128 M $
Nikko Asset Management Americas, Inc.
6.198 %
3,583,443 6.198 % 123 M $
3,551,313 6.142 % 122 M $
William Blair Investment Management LLC
6.140 %
3,549,874 6.140 % 122 M $
3,362,215 5.815 % 115 M $
Citadel Securities GP LLC
3.182 %
1,839,616 3.182 % 63 M $

Company contact information

Twist Bioscience Corp.

681 Gateway Boulevard

94080, San Francisco

+800 719 0671

http://www.twistbioscience.com
address Twist Bioscience Corporation(TWST)
  1. Stock Market
  2. Equities
  3. TWST Stock
  4. Company Twist Bioscience Corporation